These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33864388)

  • 21. Acute Heart Failure in the Course of Macrophage Activation Syndrome Due to Newly Diagnosed Systemic Lupus Erythematosus: Case Presentation and Literature Review.
    Kuna J; Chmielewski G; Jaśkiewicz Ł; Krajewska-Włodarczyk M
    Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case of using mycophenolate in combination with steroids for concurrent macrophage activation syndrome and lupus flare.
    Shah K; Porter A; Takhar G; Reddy V
    BMJ Case Rep; 2020 Apr; 13(4):. PubMed ID: 32269047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Woman With Fever and Lymphadenopathy.
    Cho J; Jong SC; Ng SB
    JAMA; 2018 Jun; 319(24):2552-2553. PubMed ID: 29946706
    [No Abstract]   [Full Text] [Related]  

  • 24. Macrophage activation syndrome at the onset of glucocorticoid-resistant systemic lupus erythematosus: a case report.
    Tulbă D; Balea M; Băicuş C
    Rom J Intern Med; 2018 Mar; 56(1):67-70. PubMed ID: 28918421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage Activation Syndrome in a Child with Juvenile Idiopathic Arthritis Secondary to SARS-CoV-2.
    Akturk H; Tanyildiz M; Erbey F; Tasdemir M; Celikyurt A; Gonen E; Bilge I
    J Trop Pediatr; 2021 May; 67(2):. PubMed ID: 34028559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A young male with more than lupus.
    Rudinskaya A; Shao M; Lahita RG
    Lupus; 2016 Nov; 25(13):1491-1496. PubMed ID: 27260659
    [No Abstract]   [Full Text] [Related]  

  • 27. Successful therapy of macrophage activation syndrome with dexamethasone palmitate.
    Nakagishi Y; Shimizu M; Kasai K; Miyoshi M; Yachie A
    Mod Rheumatol; 2016 Jul; 26(4):617-20. PubMed ID: 24754272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic lupus erythematosus after SARS-CoV-2 infection: A causal or temporal relationship?
    Gracia-Ramos AE; Saavedra MA
    Int J Rheum Dis; 2023 Dec; 26(12):2373-2376. PubMed ID: 38041650
    [No Abstract]   [Full Text] [Related]  

  • 29. Macrophage activation syndrome in a newborn: report of a case associated with neonatal lupus erythematosus and a summary of the literature.
    Heijstek V; Habib M; van der Palen R; van Doorn R; Muller PH
    Pediatr Rheumatol Online J; 2021 Feb; 19(1):13. PubMed ID: 33568193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Big Bad Wolf: Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus.
    Schulert GS
    J Rheumatol; 2022 Oct; 49(10):1082-1084. PubMed ID: 36271722
    [No Abstract]   [Full Text] [Related]  

  • 31. Rituximab therapy in refractory macrophage activation syndrome secondary to systemic lupus erythematosus.
    Bakshi J; Hassan S; D'Cruz D; Chan A
    Lupus; 2013 Dec; 22(14):1544-6. PubMed ID: 24014570
    [No Abstract]   [Full Text] [Related]  

  • 32. Systemic lupus erythematosus flare following SARS-CoV2 infection: the implication of IFNα and anti-IFNα autoantibodies.
    Mageau A; Nicaise Roland P; Goulenok T; Farkh C; Charles N; Sacre K
    Clin Exp Rheumatol; 2022 Jul; 40(7):1450. PubMed ID: 35238761
    [No Abstract]   [Full Text] [Related]  

  • 33. Erythematosus plaques with macrophage infiltration as an initial manifestation of macrophage activation syndrome in a patient with systemic lupus erythematosus.
    Tochihara M; Kasai M; Katsumata Y; Sato E; Ishiguro N; Kazama H; Sugimoto N; Ichida H; Kawaguchi Y; Yamanaka H
    Mod Rheumatol; 2016 Nov; 26(6):956-957. PubMed ID: 25036234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Case Report: A Fatal Case of West Nile Virus Meningoencephalomyelitis in a Woman with Systemic Lupus Erythematosus Initially Misdiagnosed as SARS-CoV-2 Infection.
    Schiuma M; Pezzati L; Ballone E; Borghi B; Osio M; Mattavelli D; Galimberti L; Corbellino M; Mileto D; Zanchetta N; Antinori S
    Am J Trop Med Hyg; 2021 Mar; 104(5):1716-1718. PubMed ID: 33782207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TEN/SJS-like lupus erythematosus presentation complicated by COVID-19.
    Shahidi-Dadras M; Araghi F; Ahmadzadeh A; Rakhshan A; Tabary M; Dadkhahfar S
    Dermatol Ther; 2021 Jan; 34(1):e14612. PubMed ID: 33258528
    [No Abstract]   [Full Text] [Related]  

  • 37. Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review.
    Gracia-Ramos AE; Saavedra-Salinas MÁ
    Rheumatol Int; 2021 Apr; 41(4):799-809. PubMed ID: 33543338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 infection among inpatients with systemic lupus erythematosus in France: a nationwide epidemiological study.
    Mageau A; Aldebert G; Van Gysel D; Papo T; Timsit JF; Sacre K
    Ann Rheum Dis; 2021 Aug; 80(8):1101-1102. PubMed ID: 33727216
    [No Abstract]   [Full Text] [Related]  

  • 39. Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus.
    Kondo Y; Kaneko Y; Oshige T; Fukui H; Saito S; Okayama M; Kamata H; Ishii M; Hasegawa N; Fukunaga K; Takeuchi T
    Ann Rheum Dis; 2021 May; 80(5):e77. PubMed ID: 32759254
    [No Abstract]   [Full Text] [Related]  

  • 40. Visceral Leishmaniasis Associated with Macrophage Activation Syndrome and Diffuse Alveolar Hemorrhage in a Lupus Patient.
    Costa A; Pais C; Cerqueira S; Salvador F
    Acta Med Port; 2018 Oct; 31(10):593-596. PubMed ID: 30387429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.